Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> Delegates Agree to Tighten Pandemic Regulations, Get Reality Check from Civil Society 26/01/2022 Kerry Cullinan While three independent review panels concur that the response of the World Health Organization (WHO) to COVID-19 was inadequate, member states made slow progress in charting better alternatives at the executive board meeting on Wednesday. WHO members are considering three main proposals to improve the global body’s future pandemic preparedness: Setting up a Standing Committee […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> UN Secretary General António Guterres Calls for ‘New Global Deal’ on Debt Relief, Climate and Health 17/01/2022 Elaine Ruth Fletcher International financial institutions need to extend widespread debt relief to developing countries, and private sector companies need to mend “social contracts” with societies, and in order to “beat climate, beat COVID” fight hunger – and global financial instability, said UN Secretary General António Guterres. He was speaking on the opening day of the World Economic […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Posts navigation Older postsNewer posts
Delegates Agree to Tighten Pandemic Regulations, Get Reality Check from Civil Society 26/01/2022 Kerry Cullinan While three independent review panels concur that the response of the World Health Organization (WHO) to COVID-19 was inadequate, member states made slow progress in charting better alternatives at the executive board meeting on Wednesday. WHO members are considering three main proposals to improve the global body’s future pandemic preparedness: Setting up a Standing Committee […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> UN Secretary General António Guterres Calls for ‘New Global Deal’ on Debt Relief, Climate and Health 17/01/2022 Elaine Ruth Fletcher International financial institutions need to extend widespread debt relief to developing countries, and private sector companies need to mend “social contracts” with societies, and in order to “beat climate, beat COVID” fight hunger – and global financial instability, said UN Secretary General António Guterres. He was speaking on the opening day of the World Economic […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Posts navigation Older postsNewer posts
As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> UN Secretary General António Guterres Calls for ‘New Global Deal’ on Debt Relief, Climate and Health 17/01/2022 Elaine Ruth Fletcher International financial institutions need to extend widespread debt relief to developing countries, and private sector companies need to mend “social contracts” with societies, and in order to “beat climate, beat COVID” fight hunger – and global financial instability, said UN Secretary General António Guterres. He was speaking on the opening day of the World Economic […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Posts navigation Older postsNewer posts
UN Secretary General António Guterres Calls for ‘New Global Deal’ on Debt Relief, Climate and Health 17/01/2022 Elaine Ruth Fletcher International financial institutions need to extend widespread debt relief to developing countries, and private sector companies need to mend “social contracts” with societies, and in order to “beat climate, beat COVID” fight hunger – and global financial instability, said UN Secretary General António Guterres. He was speaking on the opening day of the World Economic […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Posts navigation Older postsNewer posts
WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Posts navigation Older postsNewer posts
India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> ‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Posts navigation Older postsNewer posts
‘Vaccine for World’ Gets Emergency Use Authorization in India; Texas Children’s Hospital Grants Non-Exclusive License to Biological E 28/12/2021 Elaine Ruth Fletcher Vaccine equity advocates see huge potential in India’s decision to grant an emergency use license to CORBEVAX™, an open-license vaccine dubbed “The World’s COVID-19 Vaccine” by its developers at Texas Children’s Hospital and Baylor College of Medicine. The protein sub-unit vaccine, engineered at Baylor’s Center for Vaccine Development (CVD), received the Emergency Use Authorization (EUA) […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Posts navigation Older postsNewer posts
The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Posts navigation Older postsNewer posts
Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Posts navigation Older postsNewer posts
African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Posts navigation Older postsNewer posts